Treatment of Cushing's sundrome in the dog with an adrenocorticolytic agent (o,p'DDD).
D015065:17-Hydroxycorticosteroids / Q000652:urine; D000284:Administration, Oral; D000311:Adrenal Glands / Q000473:pathology; D000818:Animals; D003345:Corticosterone / Q000097:blood; D003480:Cushing Syndrome / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology / Q000662:veterinary*; D003632:Dichlorodiphenyldichloroethane / Q000008:administration & dosage / Q000627:therapeutic use*; D004283:Dog Diseases / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D004285:Dogs; D005260:Female; D006854:Hydrocortisone / Q000097:blood; D008297:Male; D010902:Pituitary Gland / Q000473:pathology; D010911:Pituitary Neoplasms / Q000473:pathology; D012075:Remission, Spontaneous
D015065:17-Hydroxycorticosteroids; D003632:Dichlorodiphenyldichloroethane; D003345:Corticosterone; D006854:Hydrocortisone